Request Deal Involvement
Roche completed the acquisition of Telavant Holdings from Roivant Sciences and Pfizer for $7.25bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Mayer Brown
legal advisors
Freshfields Bruckhaus Deringer
financial advisors
Citigroup
legal advisors
Davis Polk & Wardwell
or
Principals
target
TELAVANT HOLDINGS
vendor
ROIVANT SCIENCES LTD
bidder
ROCHE HOLDINGS AG
vendor
PFIZER INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite